Show Summary Details
Page of

The Pharmaceutical Phoenix Rises 

The Pharmaceutical Phoenix Rises
Chapter:
The Pharmaceutical Phoenix Rises
Author(s):

Dieter Schmidt

and Simon Shorvon

DOI:
10.1093/med/9780198725909.003.0003
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 October 2020

This chapter considers the evolution of drug therapy between 1860 and 1970, a period dominated by five compounds: bromide, phenobarbital, phenytoin, carbamazepine, and valproate. These drugs have changed the lives of people with epilepsy for the better, more perhaps than any other treatment, before or since, and deserve to be celebrated. With the possible exception of phenytoin, the antiepileptic properties of these drugs were detected largely by chance. Each though each was a child of its time, each has had both positive and negative features. These were landmarks in reducing and ameliorating seizures as a symptom of epilepsy, but are not a cure of the disease.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.